GlassScriptPhysician profile
John Austin Carlisle
NPI 1164962726
$1,745.04
in general payments reported to CMS, 2019-2025
11 companies · $793 in 2025
The $793 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.13 · 2022: $667 · 2023: $119 · 2024: $145 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766 · Travel and Lodging: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.54 |
| Travel and Lodging | $291.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $860.85 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medtronic, INC. | $604.23 | 2023-2025 | Interstim, Transorb, Signia |
| Ethicon US, LLC | $53.25 | 2025 | Echelon; Endopath |
| Stryker Corporation | $41.71 | 2022 | |
| Ge Healthcare | $38.70 | 2024 | |
| Smith+Nephew, INC. | $31.44 | 2022 | |
| Conmed Corporation | $24.59 | 2024 | Airseal |
| Angiodynamics, INC. | $23.95 | 2025 | Nanoknife |
| Cashflow Solutions, LLC | $22.76 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Kci USA, INC. | $22.43 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Innocoll Pharmaceuticals Limited | $21.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Carlisle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.